Transcriptional regulation and transformation by Myc proteins

Nature Reviews Molecular Cell Biology

Volumn 6, Issue 8, 2005, Pages 635-645

  Adhikary, Sovana ^a   Eilers, Martin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; FERRITIN; GLYCINE HYDROXYMETHYLTRANSFERASE; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE DEACETYLASE 2; INTEGRIN; IRON REGULATORY PROTEIN 2; LACTATE DEHYDROGENASE; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN P16INK4A; RAS PROTEIN; TRANSCRIPTION FACTOR E2F2; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BINDING SITE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; DNA SEQUENCE; GENE CONTROL; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BINDING SITES; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 23144464363     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1703     Document Type: Review

References (156)

1. Levens, D. Disentangling the MYC web. Proc. Natl Acad. Sci. USA 99, 5757-5759 (2002).
2. Levens, D. L. Reconstructing MYC. Genes Dev. 17, 1071-1077 (2003).
3. Eisenman, R. N. Deconstructing Myc. Genes Dev. 15, 2023-2030 (2001).
4. Wu, K. J., Polack, A. & Dalla-Favera, R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by C-MYC. Science 283, 676-679 (1999).
5. Pelengaris, S. & Khan, M. The many faces of c-MYC. Arch. Biochem. Biophys. 416, 129-136 (2003).
6. Pelengaris, S., Khan, M. & Evan, G. I. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334 (2002). Demonstrates the multiple roles of Myc in tumorigenesis.
7. Eilers, M., Schirm, S. & Bishop, J. M. The MYC protein activates transcription of the α-prothyrmosin gene. EMBO J. 10, 133-141 (1991).
8. Freytag, S. O. & Geddes, T. J. Reciprocal regulation of adipogenesis by Myc and C/EBPα. Science 256, 379-382 (1992).
9. Iritani, B. M. & Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci. USA 96, 13180-13185 (1999).
10. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779-790 (1999). Shows the link between Myc and cell growth.
11. Baudino, T. A. et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530-2543 (2002).
12. Arnold, I. & Watt, F. M. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr. Biol. 11, 558-568 (2001).
13. Frye, M., Gardner, C., Li, E. R., Arnold, I. & Watt, F. M. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793-2808 (2003).
14. Felsher, D. W. & Bishop, J. M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl Acad. Sci. USA 96, 3940-3944 (1999).
15. Mateyak, M. K., Obaya, A. J., Adachi, S. & Sedivy, J. M. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8, 1039-1048 (1997).
16. Mateyak, M. K., Obaya, A. J. & Sedivy, J. M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19, 4672-4683 (1999).
17. Trumpp, A. et al. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773 (2001).
18. de Alboran, I. M. et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14, 46-55 (2001).
19. Knoepfler, P. S., Cheng, P. F. & Eisenman, R. N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712 (2002). References 17-19 analyse the effect of Myc knockouts in mammalian organ systems.
20. Wilson, A. et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747-2763 (2004).
21. Herold, S. et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell 10, 509-521 (2002).
22. Blackwood, E. M. & Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217 (1991).
23. Blackwood, E. M., Lüscher, B. & Eisenman, R. N. Myc and Max associate in vivo. Genes Dev. 6, 71-80 (1992).
24. Ayer, D. E., Kretzner, L. & Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222 (1993).
25. Hurlin, P. J., Queva, C. & Eisenman, R. N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58 (1997).
26. Hurlin, P. J. et al. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 15, 2030-2038 (1996).
27. Zervos, A. S., Gyuris, J. & Brent, R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232 (1993).
28. Blackwell, T. K. et al. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13, 5216-5224 (1993).
29. Blackwell, T. K., Kretzner, L., Blackwood, E. M., Eisenman, R. N. & Weintraub, H. Sequence-specific DNA binding by the c-Myc protein. Science 250, 1149-1151 (1990).
30. Ayer, D. E. & Eisenman, R. N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentation. Genes Dev. 7, 2110-2119 (1993).
31. Amati, B. et al. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72, 233-245 (1993).
32. Mao, D. Y. et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13, 882-886 (2003).
33. Nair, S. K. & Burley, S. K. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112, 193-205 (2003).
34. Nilsson, J. A. et al. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol. Cell. Biol. 24, 1560-1569 (2004).
35. Hurlin. P. J. et al. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 22, 4584-4596 (2003).
36. Schreiber-Agus, N. et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487 (1998).
37. Foley, K. P. et al. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17, 774-785 (1998).
38. Nikiforov, M. A., Popov, N., Kotenko, I., Henriksson, M. & Cole, M. D. The Mad and Myc basic domains are functionally equivalent. J. Biol. Chem. 278, 11094-11099 (2003).
39. James, L. & Eisenman, R. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc. Natl Acad. Sci. USA 99, 10429-10434 (2002).
40. Peukert, K. et al. An alternative pathway for gene regulation by Myc. EMBO J. 16, 5672-5686 (1997).
41. Kim, J. W. et al. Evaluation of Myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol. Cell. Biol. 24, 5923-5936 (2004).
42. Bouchard, C. et al. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15, 2042-2047 (2001).
43. Boyd, K. E., Wells, J., Gutman, J., Bartley, S. M. & Farnham, P. J. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl Acad. Sci. USA 95, 13887-13892 (1998).
44. Li, Z. et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl Acad. Sci. USA 100, 8164-8169 (2003).
45. Waters, C. M., Littlewood, T. D., Hancock, D. C., Moore, J. P. & Evan, G. I. c-Myc protein expression in untransformed fibroblasts. Oncogene 6, 797-805 (1991).
46. Fernandez, P. C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129 (2003).
47. Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509 (2004).
48. Orian, A. et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114 (2003).
49. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N. & Edgar, B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nature Cell Biol. 7, 295-302 (2005).
50. Grandori, C. et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biol. 7, 311-318 (2005).
51. Arabi, A. et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nature Cell Biol. 7, 303-310 (2005).
52. Gomez-Roman, N., Grandori, C., Eisenman, R. N. & White, R. J. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421, 290-294 (2003).
53. Poortinga, G. et al. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J. 23, 3325-3335 (2004). References 49-53 link Myc to RNA-pol-I- and III-dependent transcription.
54. Grandori, C. et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev. 17, 1569-1574 (2003).
55. INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392-399 (2001).
56. INK4b. Nature Cell Biol. 3, 400-408 (2001). References 55 and 56 define a pathway for gene repression by Myc.
57. Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002).
58. Wanzel, M. et al. Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage. Nature Cell Biol. 7, 30-41 (2005).
59. Barsyte-Lovejoy, D., Mao, D. Y. & Penn, L. Z. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism. Oncogene 23, 3481-3486 (2004).
60. WAF1/CIP1 promoter and interacts with Sp1/Sp3. Proc. Natl Acad. Sci. USA 98, 4510-4515 (2001).
61. Izumi, H. et al. Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor. J. Cell Sci. 114, 1533-1544 (2001).
62. Roy, A. L., Carruthers, C., Gutjahr, T. & Roeder, R. G. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365, 359-361 (1993).
63. Shrivastava, A. et al. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262, 1889-1892 (1993).
64. ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431, 712-717 (2004).
65. Datta, A. et al. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J. Biol. Chem. 279, 36698-36707 (2004).
66. Oster, S. K., Mao, D. Y., Kennedy, J. & Penn, L. Z. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22, 1998-2010 (2003).
67. Bahram, F., von der Lehr, N., Cetinkaya, C. & Larsson, L. G. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95, 2104-2110 (2000).
68. Herbst, A. et al. A conserved element in Myc that negatively regulates its proapoptotic activity. EMBO Rep. 6, 177-183 (2005).
69. Herbst, A., Salghetti, S. E., Kim, S. Y. & Tansey, W. P. Multiple cell-type-specific elements regulate Myc protein stability. Oncogene 23, 3863-3871 (2004).
70. Stone, J. et al. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7, 1697-1709 (1987).
71. McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D. & Cole, M. D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374 (1998).
72. Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S. & Amati, B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15, 2069-2082 (2001).
73. Park, J., Kunjibettu, S., McMahon, S. B. & Cole, M. D. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev. 15, 1619-1624 (2001).
74. Fuchs, M. et al. The p400 complex is an essential E1A transformation target. Cell 106, 297-307 (2001).
75. Kusch, T. et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306, 2084-2087 (2004).
76. Kobor, M. S. et al. A protein complex containing the conserved Swi2/Snf2-related ATPase Swr1p deposits histone variant H2A.Z into euchromatin. PLoS Biol. 2, E131 (2004).
77. Wood, M. A., McMahon, S. B. & Cole, M. D. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol. Cell 5, 321-330 (2000).
78. Jonsson, Z. O., Jha, S., Wohlschlegel, J. A. & Dutta, A. Rvb1p/Rvb2p recruit Arp5p and assemble a functional Ino80 chromatin remodeling complex. Mol. Cell 16, 465-477 (2004).
79. Etard, C., Gradl, D., Eilers, M. & Wedlich, D. Pontin and Reptin regulate proliferation in early Xenopus embryos through the Myc/Miz pathway. Mech. Dev. (in the press).
80. Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E. & Tansey, W. P. Skp2 regulates Myc protein stability and activity. Mol. Cell 11, 1177-1188 (2003).
81. von der Lehr, N. et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11, 1189-1200 (2003).
82. Gonzalez, F., Delahodde, A., Kodadek, T. & Johnston, S. A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296, 548-550 (2002).
83. Nikiforov, M. A. et al. TRRAP-dependent and TRPAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22, 5054-5063 (2002).
84. Vervoorts, J. et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 1-7 (2003).
85. Eberhardy, S. R. & Farnham, P. J. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277, 40156-40162 (2002).
86. Bouchard, C., Marquardt, J., Bras, A., Medema, R. H. & Eilers, M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 23, 2830-2840 (2004).
87. Kanazawa, S., Soucek, L., Evan, G., Okamoto, T. & Peterlin, B. M. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22, 5707-5711 (2003).
88. Eberhardy, S. R. & Famham, P. J. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 276, 48562-48571 (2001).
89. Brenner, C. et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24, 336-346 (2005).
90. Beer, S. et al. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2, E332 (2004).
91. van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
92. Kowalczyk, A. et al. The critical role of cyclin D2 in adult neurogenesis. J. Cell Biol. 167, 209-213 (2004).
93. Kenney, A. M., Cole, M. D. & Rowitch, D. H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130, 15-28 (2003).
94. 1 arrest pathway. Mol. Cell. Biol. 19, 5913-5922 (1999).
95. Berwanger, B. et al. Loss of a Fyn-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell 2, 377-386 (2002).
96. Losses, I. S. et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc. Natl Acad. Sci. USA 99, 8886-8891 (2002).
97. Kozar, K. et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477-491 (2004).
98. Miliani de Marval, P. L. et al. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol. Cell. Biol. 24, 7538-7547 (2004).
99. Hermeking, H. et al. Identification of CDK4 as a target of c-MYC. Proc. Natl Acad. Sci. USA 97, 2229-2234 (2000).
100. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688-1702 (2001).
101. Shim, H. et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl Acad. Sci. USA 94, 6658-6663 (1997).
102. Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1-11 (1999).
103. Semenza, G. L. et al. 'The metabolism of tumours: 70 years later. Novartis Found. Symp. 240, 251-260; discussion 260-264 (2001).
104. Bowen, H. et al. c-Myc represses and Miz-1 activates the murine natural resistance-associated protein 1 promoter. J. Biol. Chem. 277, 34997-35006 (2002).
105. Nikiforov, M. A. et al. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22, 5793-5800 (2002).
106. Boon, K. et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20, 1383-1393 (2001).
107. Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J. & Schmidt, E. V. Increased expression of eukaryotic translation initiation factors elF-4E and elF-2α in response to growth induction by c-myc. Proc. Natl Acad. Sci. USA 90, 6175-6178 (1993).
108. Greasley, P. J., Bonnard, C. & Amati, B. Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. Nucleic Acids Res. 28, 446-453 (2000).
109. Menssen, A. & Hermeking, H. Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc. Natl Acad. Sci. USA 99, 6274-6279 (2002).
110. Beier, R. et al. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by myc are genetically separable events. EMBO J. 19, 5813-5823 (2000).
111. Hannon, G. J. & Rossi, J. J. Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378 (2004).
112. Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: marvelouslY complex. Adv. Cancer Res. 84, 81-154 (2002).
113. Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
114. INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 4, 301-310 (2003).
115. Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol. Cell. Biol. 23, 2859-2870 (2003).
116. Sears, R. et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514 (2000).
117. Yen, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308-318 (2004).
118. Gregory, M. A., Qi, Y. & Hann, S. R. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278, 51606-51612 (2003).
119. Welcker, M., Orian, A., Grim, J. A., Eisenman, R. N. & Clurman, B. E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 14, 1852-1857 (2004).
120. Welcker, M. et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl Acad. Sci. USA 101, 9085-9090 (2004).
121. Yada, M. et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23, 2116-2125 (2004). References 117-121 show how Myc is degraded by the proteasome.
122. Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. & Weinberg, R. A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219-231 (2003).
123. Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
124. Endo, T. & Nadal-Ginard, B. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol. Cell. Biol. 6, 1412-1421 (1986).
125. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
126. Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658-2669 (1999).
127. ARF) and is amplified in a subset of human breast cancers. Nature Genet. 26, 291-299 (2000).
128. Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690 (1999).
129. Aslanian, A., Iaquinta, P. J., Verona, R. & Lees, J. A. Repression of the Art tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev. 18, 1413-1422 (2004).
130. Baudino, T. A. et al. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol. Cell 11, 905-914 (2003).
131. Leone, G. et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105-113 (2001).
132. Juin, P., Hueber, A. O., Littlewood, T. & Evan, G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13, 1367-1381 (1999).
133. Soucie, E. L. et al. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol. Cell. Biol. 21, 4725-4736 (2001).
134. Mitchell, K. O. et al. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res. 60, 6318-6325 (2000).
135. Egle, A., Harris, A. W., Bouillet, P. & Cory, S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl Acad. Sci. USA 101, 6164-6169 (2004).
136. L or Bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21, 5063-5070 (2001).
137. Ruggero, D. et al. The translation factor elF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Med. 10, 484-486 (2004).
138. Wendel, H. G. et al. Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature 428, 332-337 (2004).
139. 1/S arrest following ionizing radiation. Mol. Cell. Biol. 22, 1819-1833 (2002).
140. Vafa, O. et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function. A mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002). Provides a potential link between Myc and genomic instability.
141. Karlsson, A. et al. Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc. Natl Acad. Sci. USA 100, 9974-9979 (2003).
142. Karlsson, A. et al. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 101, 2797-2803 (2003).
143. Rockwood, L. D., Felix, K. & Janz, S. Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma. Mutat. Res. 548, 117-125 (2004).
144. Sargent, L. M. et al. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-α in the liver. Am. J. Pathol. 154, 1047-1055 (1999).
145. Soucek, L. & Evan, G. Myc - is this the oncogene from hell? Cancer Cell 1, 406-408 (2002).
146. D'Cruz, C. M. et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nature Med. 7, 235-239 (2001).
147. Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999).
148. Shachaf, C. M. et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112-1117 (2004).
149. Bello-Fernandez, C., Packham, G. & Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-MYC. Proc. Natl Acad. Sci. USA 90, 7804-7808 (1993).
150. Lewis, B. C. et al. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Res. 60, 6178-6183 (2000).
151. Wood, L. J. et al. HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol. 20, 5490-5502 (2000).
152. Orre, R. S., Cotter, M. A., Subramanian, C. & Robertson, E. S. Prothymosin α functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro. J. Biol. Chem. 276, 1794-1799 (2001).
153. Zhu, P. et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463 (2004).
154. Bouchard, C. et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321-5333 (1999).
155. Oliver, T. G. et al. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc. Natl Acad. Sci. USA 100, 7331-7336 (2003).
156. Sears, R., Ohtani, K. & Nevins, J. R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 17, 5227-5235 (1997).